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To investigate the molecular basis of oncogenesis induced by the v-myc oncogene of avian myelocytomatosis virus MC29,
we developed a conditional cell transformation system in which expression of the MC29 v-myc allele is dependent on a
doxycycline-sensitive transactivator (tTA). Clonal lines of quail embryo fibroblasts transformed by doxycycline-controlled
v-myc revert to the normal phenotype and lose their ability to grow in soft agar after the addition of doxycycline. Repression
of v-myc causes the cells to withdraw from the cell cycle, and long-term survival in culture requires reexpression of v-myc.
Although complete repression of v-myc mRNA and v-Myc protein in these cells occurs within 14 h after the addition of
doxycycline, the first morphological alterations are observed after 24 h, and after 3 days, the morphology changed entirely
from small rounded cells showing a typical myc-transformed phenotype to large flat cells resembling normal fibroblasts.
Cells exposed to doxycycline for 3 days reexpressed v-myc within 24 h after withdrawal of the drug from the culture medium,
partial retransformation occurred after 2 days, and complete morphological transformation was reestablished after 6 days.
Analogous results were obtained with a cell line in which expression of the v-myc allele is dependent on a reverse
transactivator (rtTA) that is activated by doxycycline. The striking differential expression of known transformation-sensitive
genes and of new candidate v-myc target genes revealed the tightness of the doxycycline-controlled v-myc expression
system. The data also indicate that expression of v-myc in these cells is indispensable for enhanced proliferation,
transformation, and immortalization. © 1999 Academic Press
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aINTRODUCTION
Conditionally transformation-defective mutants of
ous sarcoma virus specifying a temperature-sensitive
rotein product (Src) of the v-src oncogene have played
pivotal role in establishing the oncogene concept and
n elucidating the molecular mechanisms of cell trans-
ormation (Hanafusa, 1977; Martin, 1970; Vogt, 1977).
nalogous mutants of the avian acute leukemia virus
C29 carrying the v-myc oncogene (Bister and Jansen,
986; Erisman and Astrin, 1988) could not be isolated,
ossibly due to the fact that the Myc protein is a regu-
atory DNA-interacting protein (Grandori and Eisenman,
997) and not an enzyme like the protein kinase Src. The
ack of such mutants has rendered difficult investigations
nto the molecular mechanisms of cell transformation
nd tumor induction by v-myc, in particular, the search for
ownstream targets of this oncogene. In recent years,
everal strategies for the conditional expression of ba-
ically any gene of interest have been developed and
pplied to oncogene research. One approach uses fu-
ion of the protein product of the relevant gene with the
igand-binding domain of steroid hormone receptors,
enerating a chimeric protein whose functional activa-
1 To whom reprint requests should be addressed. Fax: 43-512-507-
s894. E-mail: klaus.bister@uibk.ac.at.
193ion is ligand dependent. In the absence of the hormone
igand, such hybrid proteins are biochemically inactive
ue to sequestration by heat shock proteins. This strat-
gy was originally used to generate a hormone-depen-
ent receptor chimera of the adenovirus E1A protein
Picard et al., 1988) and then of retroviral transforming
roteins and their cellular homologs, including the hu-
an c-Myc protein (Eilers et al., 1989), the MC29 v-Myc
rotein (Tikhonenko et al., 1995), or the avian sarcoma
irus ASV17 v-Jun protein (Kruse et al., 1997). A second
trategy uses prokaryotic regulatory protein domains
nd cis-acting control elements of the tetracycline-resis-
ance operon of Escherichia coli to regulate transcription
f the eukaryotic gene of interest (Gossen and Bujard,
992; Gossen et al., 1993, 1995). Tetracycline-controlled
ransactivators generated by fusion of the tet repressor
ith the transactivating domain of the herpes simplex
irus VP16 protein were used to activate transcription of
he relevant gene placed under control of a minimal
romoter linked to tet operator sequences. Transactiva-
ors that are active only in the absence or presence of
etracycline or its derivatives were engineered, allowing
ifferential transcriptional control of the gene of interest
y the addition or removal of the drug (Gossen and
ujard, 1992; Gossen et al., 1995). Examples for the
pplication of such control systems in oncogene re-
earch are the conditional expression of the human
0042-6822/99 $30.00
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194 OBERST ET AL.-myc oncogene in human neuroblastoma cells (Lutz et
l., 1996) or of the v-myc oncogene in rat neuronal pro-
enitor cells (Hoshimaru et al., 1996).
Here we describe the generation of a doxycycline-
ontrolled expression system of the MC29 v-myc allele
nd the establishment of conditionally v-myc-trans-
ormed quail embryo fibroblast (QEF) lines, analyze dif-
erential expression of new target genes in these cells,
nd compare our results on conditional avian fibroblast
ransformation using transcriptional control of v-myc with
hose obtained with a conditional system based on hor-
one-dependent Myc regulation at the protein level (Tik-
onenko et al., 1995).
RESULTS
onditional cell transformation by doxycycline-
ontrolled v-myc expression
To establish long-term cell lines that express the v-myc
ncogene under the control of the transactivator tTA,
hich binds to tet operator sequences and activates
FIG. 1. Schematic diagram of the plasmids used for the generation o
uman cytomegalovirus immediate-early gene 1 promoter/enhancer (P
tTA) containing the tet repressor from Escherichia coli or a mutant deri
rom herpes simplex virus (Gossen et al., 1995; Gossen and Bujard, 199
bsence of doxycycline, whereas rtTA binds to tet operator sequences a
eomycin resistance gene; Ampr, ampicillin resistance gene; colE1 or
ignal. (B) The response plasmid pUHD10–3 contains a tTA/rtTA-dep
perator O2 of the Tn10-specified tetracycline resistance operon from E
ujard, 1992). By inserting the v-myc coding region (black box) of M
autenberger et al., 1981; Reddy et al., 1983) into pUHD10–3, the plas
ependent expression of v-myc.ranscription only in the absence of doxycycline, two vonstructs were cotransfected into QEFs in the absence
f doxycycline: pUHD15–1neo constitutively expressing
TA (Gossen and Bujard, 1992; Resnitzky et al., 1994) (Fig.
A), and pUHD10–3myc expressing the MC29 v-myc al-
ele under control of a minimal cytomegalovirus promoter
used to seven repeats of tet operator sequences (Fig.
B). To establish cell lines that express v-myc under the
ontrol of the reverse transactivator rtTA, which is active
nly in the presence of doxycycline, pUHD17–1neo con-
titutively expressing rtTA (Gossen et al., 1995) (Fig. 1A)
nd pUHD10–3myc were cotransfected into QEFs in the
resence of doxycycline. After 2 weeks under G418 se-
ection, 47 v-myc-transformed colonies derived from the
ransfection with pUHD15–1neo and 15 derived from the
ransfection with pUHD17–1neo were isolated and prop-
gated. Four of the cell clones containing the tTA trans-
ctivator (Q/tM8, Q/tM15, Q/tM21, and Q/tM27) and one
lone containing the rtTA transactivator (Q/tMON) could
e cultured for .3 months and further analyzed. Clones
/tM8 and Q/tM21 have been passaged for .8 months
o far and can be frozen and rethawed without loss of
ycycline-controlled v-myc expression system. (A) Under control of the
UHD15–1neo and pUHD17–1neo encode transactivator proteins (tTA,
hereof (reverse repressor) fused to the transactivation domain of VP16
binds to tet operator sequences and activates transcription only in the
ivates transcription only in the presence of doxycycline. Neor indicates
li origin of replication; and SV40 An, simian virus 40 polyadenylation
promoter (PhCMV*21) constructed by fusing seven repeats of the tet
o the human cytomegalovirus minimal promoter (PhCMV*) (Gossen and
roviral DNA from plasmid clone pMC29-B (Bister et al., 1982, 1987;
HD10–3myc was generated, allowing doxycycline-regulated tTA/rtTA-f a dox
hCMV), p
vative t
2). tTA
nd act
i, E. co
endent
. coli t
C29 p
mid pUiability. As a control for possible effects of doxycycline
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195CONDITIONAL CELL TRANSFORMATION BY v-mycr tTA expression on cellular growth properties, QEFs
ere transfected with pUHD15–1neo alone. After 2
eeks, a G418-resistant mass cell culture (Q/tTA) was
btained. Q/tTA cells and untransfected QEFs were cul-
ured in the presence or in the absence of doxycycline.
he addition of the drug to these cells had no apparent
ffect on cell growth or morphology (data not shown),
hich is consistent with previous findings that low con-
entrations of tetracycline and its derivatives are non-
oxic to eukaryotic cells (Gossen and Bujard, 1992; Gos-
en et al., 1995). The presence of the tTA transactivator in
/tTA cells was verified by the strong (;250-fold) acti-
ation of the luciferase response plasmid pUHC13–3
Gossen and Bujard, 1992) transiently transfected into
hese cells (data not shown).
To examine whether Q/tM cells express v-myc in a
oxycycline-regulatable manner, transformed cells of the
ive Q/tM clones were grown in the absence or presence
f doxycycline for 3 days. The immunoblot analysis
FIG. 2. Conditional cell transformation by v-myc. pUHD15–1neo and
UHD10–3myc, or pUHD17–1neo and pUHD10–3myc, were cotrans-
ected into QEFs. Morphologically transformed cell clones resistant to
418 were isolated after 2 weeks and propagated in culture. Five cell
lones survived for .3 months and developed into lines. Cell lines
/tM8, Q/tM15, Q/tM21, and Q/tM27, which were all derived by cotrans-
ection of pUHD15–1neo and pUHD10–3myc, were continuously grown
n the absence of doxycycline (2) or in the presence of doxycycline for
days (1), and extracts were prepared for immunoblot analysis. Cell
lone Q/tMON, which was derived by cotransfection of pUHD17–1neo
nd pUHD10–3myc, was continuously grown in the presence of doxy-
ycline (1) or in the absence of doxycycline for 3 days (2), and extracts
ere prepared for immunoblot analysis. Lysates of normal QEFs and of
ells from the MC29-transformed quail fibroblast line Q8 were used as
ontrols. Proteins from equal numbers of cells (1.25 3 105) were
nalyzed by SDS–PAGE (top, 10% w/v; bottom, 13% w/v) and immuno-
lotting using polyclonal antisera directed against recombinant v-Myc
top) or CRP2 (bottom) proteins. The CRP2 protein is encoded by the
SRP2 gene, whose expression is suppressed in transformed avian
ibroblasts (Weiskirchen and Bister, 1993; Weiskirchen et al., 1995). The
ositions of the 54-kDa v-Myc protein encoded by pUHD10–3myc, of
he 110-kDa Gag–Myc hybrid protein encoded by MC29 (Bister et al.,
977), of the 21-kDa CRP2 protein (Weiskirchen and Bister, 1993), and
f molecular weight markers are indicated in the margin.hown in Fig. 2 revealed that the v-Myc protein with the Pxpected apparent molecular weight of 54,000 (Bister
nd Jansen, 1986) was present at high amounts in cells
ontaining the tTA-dependent v-myc allele (Q/tM8,
/tM15, Q/tM21, and Q/tM27) only in the absence of
oxycycline and in cells containing the rtTA-dependent
-myc allele (Q/tMON) only in the presence of doxycy-
line. The amount of v-Myc in these cells is comparable
o that of the 110-kDa Gag–Myc hybrid protein (Bister et
l., 1977) in nonconditionally MC29-transformed Q8 cells
Fig. 2). To test whether activation or repression of v-myc
eads to a concurrent change in the expression pattern of
known transformation-sensitive gene, the same cell
xtracts were analyzed by immunoblotting using an an-
iserum against the LIM domain protein CRP2, the prod-
ct of the CSRP2 gene that was discovered on the basis
f its strong transcriptional suppression in transformed
vian fibroblasts (Weiskirchen and Bister, 1993;
eiskirchen et al., 1995). CRP2 was detected at high
mounts only in cells in which expression of v-myc was
uppressed or in normal QEFs (Fig. 2). Accordingly, re-
ression of the conditional v-myc allele in all five cell
lones, by either the addition or the removal of doxycy-
line, led to a reversion of the transformed phenotype
haracterized by a typical myc-transformed cell morphol-
gy to an untransformed phenotype resembling normal
ibroblast morphology (see below).
In a titration experiment designed to determine the
inimal effective dose of doxycycline, a concentration of
.3 ng of the drug/ml of culture medium was found to be
ufficient for complete reversion of myc-induced trans-
ormation in Q/tM8 and in Q/tM21 cells, whereas 330
g/ml was needed for maintaining the transformed state
f Q/tMON cells. Concentrations of up to 2 mg/ml were
qually effective, with no apparent cytotoxicity. There-
ore, 1 mg/ml doxycycline was used in most of the sub-
equent studies. For cells containing the tTA-dependent
-myc allele, doxycycline was initially added at 1 mg/ml,
nd after 2 days, the concentration was reduced to 50
g/ml. This allowed efficient removal of the drug from the
ells at day 3 in the time course experiments (see be-
ow).
ellular and molecular events after v-myc
uppression or reexpression
Transformed Q/tM8 cells were exposed to doxycycline
or increasing time periods (Figs. 3A–3C), and trans-
ormed Q/tMON cells were deprived of doxycycline for
nalogous periods of time (Figs. 3G–3I). Partial reversion
f cell transformation was visible after 1 day, whereas
omplete reversion to an untransformed phenotype was
ompleted after 3 days of treatment. Retransformation
as then initiated by removing doxycycline from the
edium of subconfluent Q/tM8 cells or by adding doxy-
ycline to the medium of subconfluent Q/tMON cells.
artial retransformation was visible after 2 days,
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196 OBERST ET AL.hereas full retransformation required up to 6 days of
ulture in the absence or presence, respectively, of doxy-
ycline (Figs. 3D–3F and 3J–3L). It should be noted that
ot all cells reentered the cell cycle and underwent
orphological retransformation. A substantial fraction of
ells kept the untransformed phenotype. Also, it was not
ossible to retransform Q/tM8 cells that had been in the
everted state for $7 days. In comparison with normal
FIG. 3. Time course of doxycycline-dependent morphological revers
ensity of 6.0 3 104–2.0 3 105 cells/35-mm dish and were not trans
TA-dependent v-myc allele were grown in the absence of doxycycline (A
day (B) and 3 days (C) after the addition of the drug. Then, doxycyclin
ere taken 1 day (D), 4 days (E), and 6 days (F) thereafter. (G–L) Trans
n the presence of doxycycline (G). Doxycycline was removed, and phas
f the drug. Then, doxycycline was added to the reverted cells (I), and
hereafter.EFs, the reverted cells are larger and more adherent wnd less dense in phase-contrast microscopy and re-
emble senescent or differentiated cells. A similar phe-
omenon was reported for chicken hematopoietic cells
onditionally transformed by an estrogen-dependent
-Myb expression system (Engelke et al., 1997). When
strogen was added back within 48 h after withdrawal,
he transformed phenotype was reassumed by most of
he cells, whereas readdition of estrogen at 96 h after
retransformation of Q/tM8 and Q/tMON cells. Cells were seeded at a
during the time course. (A–F) Transformed Q/tM8 cells containing a
cycline was added, and phase-contrast micrographs (773) were taken
removed from the reverted cells (C), and phase-contrast micrographs
Q/tMON cells containing an rtTA-dependent v-myc allele were grown
rast micrographs were taken 1 day (H) and 3 days (I) after the removal
-contrast micrographs were taken 1 day (J), 4 days (K), and 6 days (L)ion and
ferred
). Doxy
e was
formed
e-cont
phaseithdrawal was unable to cause dedifferentiation.
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197CONDITIONAL CELL TRANSFORMATION BY v-mycA direct explanation for the delays in morphological
lterations during reversion and retransformation
ould be that repression and induction of v-myc by
oxycycline occurred slowly. Therefore, we analyzed
he time course of v-myc repression and reexpression
fter the addition and removal of doxycycline in Q/tM8
ells by Northern and Western analyses (Fig. 4). Trans-
ormed Q/tM8 cells were exposed to doxycycline for
ifferent lengths of time over a 3-day period. Then,
oxycycline was removed from the reverted cells, and
he cells were incubated in the absence of the drug for
, 4, or 6 days. Total RNA and protein were extracted at
ach time point. Equal loading of RNA and protein on
els was confirmed by ethidium bromide staining of
NA and Ponceau S staining of blotted proteins, re-
pectively. Significantly, repression of v-myc was
ound to be very rapid. The level of the 1.9-kb v-myc
RNA starts to decrease within 1 h after the addition
f doxycycline, and both v-myc mRNA (Fig. 4A) and
-Myc protein (Fig. 4B) are strongly reduced within
FIG. 4. Kinetics of doxycycline-regulated v-myc expression in Q/tM8
ere not transferred during the time course. Transformed Q/tM8 cells
ime periods indicated. After 3 days of incubation in doxycycline, the d
bsence of doxycycline for an additional 1, 4, or 6 days, correspon
C29-transformed Q8 cells, and QEFs expressing only the tTA trans
ransformation-sensitive CSRP2 gene. (A) Northern analysis of equal a
ybridized with 32P-labeled DNA (6.0 3 107 cpm) from the EcoRI insert f
or 24 h using an intensifying screen. The filter was reprobed success
C29 proviral DNA (cf. Fig. 1) (5.5 3 107 cpm; 24-h exposure) and from
xposure). The positions of ribosomal RNAs are indicated in the marg
hown. Cell extracts for protein analysis were prepared in parallel with
qual numbers of cells (1.25 3 105) were analyzed by SDS–PAGE (to
irected against recombinant v-Myc (top) or CRP2 (bottom) proteins. T
10-kDa Gag–Myc hybrid protein encoded by MC29 (Bister et al., 1977)
eight markers are indicated in the margin.4 h after the addition of the drug. This is in contrast to Ihe extended time period required for complete rever-
ion of cell transformation. Reexpression of v-myc
RNA and v-Myc protein occurred within 1 day after
he removal of doxycycline from the culture medium of
ubconfluent cells and reached peak levels 6 days
fter removal of the drug. The delay of v-myc reexpres-
ion is possibly due to residual amounts of doxycy-
line in the cells. This is supported by an analogous
xperiment with Q/tMON cells, in which efficient reex-
ression of v-myc occurred 1 day after the addition of
he drug (not shown).
As a transformation-sensitive parameter, the expres-
ion kinetics of the CSRP2 gene were analyzed. Expres-
ion of CSRP2 mRNA and CRP2 protein in Q/tM8 cells
as detectable within 2 days after the addition of doxy-
ycline and reached levels as high as in untransformed
ibroblasts after 3 days (Figs. 4A and 4B). Removal of
oxycycline led to an immediate decrease of CSRP2
RNA, with nearly complete silencing of the gene oc-
urring within 6 days after removal of the drug (Fig. 4A).
ells were seeded at a density of 2.2–3.5 3 106 cells/100-mm dish and
ing a tTA-dependent v-myc allele were exposed to doxycycline for the
s removed from the reverted cells, and the cells were cultured in the
days 4, 7, and 9 after the addition of doxycycline. Normal QEFs,
or (Q/tTA) were used as controls for expression of myc and of the
(20 mg) of total RNAs from the indicated cell sources. The filter was
t of a quail CSRP2 cDNA clone, and the autoradiograph was exposed
ith 32P-labeled DNA from the v-myc-specific PstI–SspI subfragment of
RI insert fragment of a quail GAPDH cDNA clone (9.8 3 107 cpm; 24-h
n immunoblot analysis of cell extracts from the indicated sources is
A extracts used for the Northern analysis shown in (A). Proteins from
w/v; bottom, 13% w/v) and immunoblotting using polyclonal antisera
itions of the 54-kDa v-Myc protein encoded by pUHD10–3myc, of the
21-kDa CRP2 protein (Weiskirchen and Bister, 1993), and of molecularcells. C
contain
rug wa
ding to
activat
mounts
ragmen
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the Eco
in. (B) A
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198 OBERST ET AL.oval of doxycycline occurred at a significantly lower
ate (Fig. 4B), possibly due to the high stability of the
RP2 protein (unpublished data).
The 2.3-kb c-myc mRNA was detectable in normal
EFs, in control Q/tTA cells, and, at low levels, in
everted Q/tM8 cells but was completely suppressed
n the transformed Q8 and Q/tM8 cells (Fig. 4A). This is
n agreement with the previously reported suppression
f the endogenous c-myc gene by exogenous dereg-
lated myc alleles, like v-myc (Penn et al., 1990). The
evel of GAPDH mRNA was highest in transformed
ells, like Q8 or Q/tM8 cells without doxycycline; lower
n untransformed QEFs or control Q/tTA cells; and
owest in completely reverted Q/tM8 cells in the pres-
nce of doxycycline (Fig. 4A). Increased expression of
APDH mRNA in transformed fibroblasts with their
igh metabolic rate has been reported previously
Weiskirchen et al., 1993). The strong reduction of the
lycolytic enzyme gene expression in reverted Q/tM8
ells may be due to the very low proliferation and
etabolic rate of these cells.
ependence of transformation parameters on v-myc
xpression
Transformed Q/tM8 and Q/tM21 cells grow very rap-
dly, with doubling times of 22–25 h, and reach densities
f up to 8 3 106 cells/35-mm dish (Figs. 5A and 5B),
omparable to the growth rate of the established MC29-
ransformed Q8 cell line (not shown). Transformed
/tMON cells grow more slowly, with doubling times of
4 h, and reach densities of 3 3 106 cells/35-mm dish
Fig. 5C), which is lower than the growth rates of normal
EFs (not shown) or control Q/tTA cells with doubling
imes of 45 h (Fig. 5D). To test whether the transformed
/tM cells require v-myc expression to maintain the
bserved proliferation rates, the growth properties of
/tM8, Q/tM21, Q/tMON, and control Q/tTA cells were
ompared in the presence and absence of doxycycline.
epression of v-myc by the addition of doxycycline to
/tM8 and Q/tM21 or by the removal of doxycycline from
/tMON cells resulted in complete withdrawal from the
ell cycle (Figs. 5A–5C). When doxycycline was removed
rom a Q/tM8 culture after 3 days of v-myc repression,
he cells reentered the cell cycle and reached a final cell
ensity equivalent to that of Q/tM8 cells grown continu-
usly in the absence of doxycycline (Fig. 5A). Similar
esults were obtained in an analogous experiment with
/tMON cells (not shown). These data suggest that v-myc
xpression is sufficient to stimulate cell cycle progres-
ion in quiescent cells and that its continuous expres-
ion is necessary for the proliferation of Q/tM cells.
lthough the activation of c-myc in fibroblasts rendered
uiescent by serum-starvation was shown to induce ap-
ptosis (Evan et al., 1992; Harrington et al., 1994), no
poptosis was observed in Q/tM cells on reexpression of d-myc, confirming that myc-induced apoptosis in nonpro-
iferating cells is dependent on a state of quiescence
nduced by the absence of serum survival factors (Har-
ington et al., 1994). At maximum density, v-myc-
xpressing cells, unlike untransformed cells, continued
o divide, but a fraction of cells started to detach from the
ish, so the cell number on the dish remained constant
Figs. 5A–5C). Doxycycline or expression of the tTA trans-
ctivator alone had no influence on growth properties
ecause the growth rates and maximum densities of
ontrol Q/tTA cells were the same in the presence (at 1
g/ml) or absence of doxycycline (Fig. 5D).
To test whether the conditionally transformed Q/tM
lones are capable of anchorage-independent growth,
ransformed Q/tM8, Q/tM21, and Q/tMON cells were
eeded in soft agar in the presence or absence of doxy-
ycline (Table 1). After 2 weeks in doxycycline-free soft
gar, 7.3% of Q/tM8 cells and 2.8% of Q/tM21 cells (Table
) had produced agar colonies that were similar in size
nd morphology to those produced by ;20% of the cells
rom the established v-myc-transformed cell line Q8 in
he presence or absence of doxycycline (Table 1, Fig. 6).
n the presence of doxycycline (50 ng/ml), neither Q/tM8
or Q/tM21 cells produced any agar colonies (Table 1,
ig. 6). Q/tMON cells produced agar colonies only in the
resence of doxycycline (1 mg/ml), and normal QEFs
roduced no colonies in the presence or absence of
oxycycline. In summary, all parameters of transforma-
ion tested for Q/tM cells are strictly dependent on the
xpression of v-myc, including cell morphology, expres-
ion of transformation-sensitive genes, enhanced prolif-
ration, and anchorage-independent growth.
ifferential gene expression in conditionally v-myc-
ransformed fibroblasts
Several cellular genes of known or unknown function
ave been identified whose expression is suppressed in
ransformed fibroblasts. The expression of these genes
nd of two new candidate myc target genes in condition-
lly transformed Q/tM cells was analyzed by Northern
lotting (Fig. 7). RNA was extracted from Q/tM8 cells
rown in the absence or in the presence of doxycycline.
NAs from normal QEFs and from the MC29-transformed
8 cell line were used as controls. Equal loading of
NAs was confirmed by ethidium bromide staining. Hy-
ridization with a v-myc-specific probe (Fig. 7, top) re-
ealed the presence of MC29 genomic RNA in Q8 cells
Duesberg et al., 1977), of v-myc mRNA specified by
UHD10–3myc in Q/tM8 cells in the absence of doxycy-
line, and of c-myc mRNA in normal QEFs (Hartl et al.,
995) and in Q/tM8 cells in the presence of doxycycline.
Quail cDNA clones of the transformation-sensitive
enes CSRP2, CO6, nov, pro-a2(I) collagen, and os-
eonectin were all isolated by subtractive hybridization or
ifferential display analysis of mRNAs from normal QEFs
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199CONDITIONAL CELL TRANSFORMATION BY v-mycnd Q8 cells (Oberst et al., 1997; Weiskirchen and Bister,
993). The transcription of all of these genes is com-
letely switched off by v-myc-induced cell transforma-
ion, both in the nonconditionally transformed cell line Q8
nd in the Q/tM8 cell line in the absence of doxycycline
Fig. 7). The addition of doxycycline and inactivation of
he tTA-dependent v-myc allele in Q/tM8 cells restores
ranscription of all of these genes, mostly to levels com-
arable to those in normal QEFs (Fig. 7). Analogous
xpression patterns of the CSRP2 and CO6 genes were
lso observed in Q/tMON cells (data not shown). Both the
SRP2 gene and the CO6 gene were originally isolated
n the basis of their strong transcriptional suppression in
-myc-transformed avian fibroblasts, but the suppression
as also observed in cells transformed by other onco-
enes or by a chemical carcinogen (Oberst et al., 1997;
eiskirchen and Bister, 1993). The CRP2 protein product
rug was removed from one half of the dishes [1 dox(3 days)/2 dox].
B) Growth rates of Q/tM21 cells containing a tTA-dependent v-myc
llele grown in the presence (1 dox) or absence (2 dox) of doxycy-
line. Cells were seeded at a density of 2.5 3 105 cells/35-mm dish in
oxycycline-free medium. The next day, doxycycline was added to one
alf of the dishes. (C) Q/tMON cells containing an rtTA-dependent v-myc
llele were seeded at a density of 4.0 3 105 cells/35-mm dish in
edium-containing doxycycline. The next day, cells were incubated in
he presence (1 dox) or absence (2 dox) of the drug. (D) To rule out
ossible effects on cell proliferation by the tTA transactivator itself, the
rowth rate of QEFs transfected with pUHD15–1neo alone (Q/tTA) and
eeded at a density of 2.5 3 105 cells/35-mm dish was analyzed in the
TABLE 1
Conditional and Nonconditional Colony Formation by v-myc-
Transformed Avian Fibroblasts
Cells
Colony formation in soft agara
2Doxycycline 1Doxycycline
Colonies/cells
seeded
Average
percentage
Colonies/cells
seeded
Average
percentage
/tM8 1,469/20,000 7.3% 0/20,000 0.0%
1,444/20,000 0/250,000
/tM21 579/20,000 2.8% 0/20,000 0.0%
545/20,000 0/250,000
/tMON 0/20,000 0.0% 148/20,000 0.6%
0/250,000 101/20,000
8 1,710/10,000 19.9% 1,970/10,000 21.0%
2,277/10,000 2,238/10,000
EF 0/250,000 0.0% 0/250,000 0.0%
0/250,000 0/250,000
a Soft agar colony assays of the cell lines Q/tM8 and Q/tM21 con-
aining a tTA-dependent v-myc allele, the cell line Q/tMON containing an
tTA-dependent v-myc allele, the established MC29-transformed quail
ell line Q8, or normal QEFs were carried out according to published
rocedures (Bister et al., 1977) in the presence or absence of doxycy-
line. Colony numbers are from two independent experiments each.FIG. 5. Growth rates of conditionally transformed Q/tM lines. Cells
rom three parallel dishes were counted every 2 or 3 days, and the
ulture medium was renewed every 2 days. (A) Growth properties of
/tM8 cells containing a tTA-dependent v-myc allele. Cells were
eeded at a density of 2.5 3 105 cells/35-mm dish in the absence of
oxycycline. The next day, one third of the dishes remained in doxycy-
line-free medium (2 dox), whereas doxycycline was added to tworesence or absence of doxycycline.
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200 OBERST ET AL.f the CSRP2 gene contains two zinc-binding LIM do-
ains (Kontaxis et al., 1998; Konrat et al., 1997, 1998;
eiskirchen and Bister, 1993) and belongs to the CRP
rotein family, whose members are implicated in regu-
atory processes, including muscle cell differentiation
nd growth control (Arber et al., 1997; Pomie`s et al., 1997;
eiskirchen et al., 1995). The CO6 gene encodes a
rotein structurally and functionally related to mamma-
ian potassium channel regulatory subunits (Oberst et al.,
997; P. Fuchs, C. Oberst, and K. Bister, unpublished
ata). The nov proto-oncogene was originally identified
ased on its overexpression in chicken nephroblasto-
as induced by myeloblastosis-associated virus type 1
Joliot et al., 1992). Interestingly, expression of nov was
reviously reported to be suppressed in chicken embryo
ibroblasts transformed by the v-src, v-erbB, v-mil, v-crk,
r v-ras oncogene and to be highest in quiescent cells
Scholz et al., 1996). The quail nov gene isolated here
isplays 98% identity at the deduced amino acid se-
uence level with the chicken homolog (unpublished
ata), and strong repression of nov also occurs in the
ourse of v-myc-induced cell transformation (Fig. 7). The
bserved expression patterns of the genes encoding the
xtracellular matrix proteins pro-a2(I) collagen and os-
eonectin (SPARC) confirm and extend previous reports.
FIG. 6. Conditional agar colony formation by Q/tM21 cells. Equal
umbers (2.5 3 105) of cells from the Q/tM21 line containing a tTA-
ependent v-myc allele (A and B), from the MC29-transformed Q8 line
C and D), or from normal QEF (E and F) were seeded in soft agar on
5-mm dishes in the absence (A, C, and E) or presence (B, D, and F) of
oxycycline. Bright-field micrographs (123) were taken after 14 days.verexpression of c-myc in mouse fibroblasts was khown to cause transcriptional suppression of several
ollagen genes, including the one encoding pro-a2(I)
ollagen, apparently via an indirect mechanism involving
ther transcription factors (Yang et al., 1991, 1993). A
trong decrease in osteonectin mRNA in comparison to
ts level in normal fibroblasts was observed in v-src-
ransformed chicken embryo fibroblasts (Young et al.,
FIG. 7. Differential expression of transformation-sensitive genes and
utative myc target genes in conditionally and nonconditionally v-myc-
ransformed cells. Equal amounts (20 mg/lane, except for the panels
abeled CO6, VCB2, and S17, in which 30 mg were used) of total RNAs
rom normal QEFs, from the MC29-transformed cell line Q8, and from
/tM8 cells containing a tTA-dependent v-myc allele, grown in the
bsence (2) or presence for 3 days (1) of doxycycline, were analyzed
y Northern blotting. The following 32P-labeled DNA probes were used:
he SalI–BamHI v-myc-specific subfragment of MC29 proviral DNA
4.4 3 107 cpm, 5-day exposure), the EcoRI insert fragment of a quail
SRP2 cDNA clone (6.9 3 107 cpm, 5-day exposure), the EcoRI insert
ragment of a quail CO6 cDNA clone (6.1 3 107 cpm, 4-day exposure),
he NotI insert fragment of a quail nov cDNA clone (6.2 3 107 cpm, 16-h
xposure), the NotI insert fragment of a quail pro-a2(I) collagen cDNA
lone (5.4 3 107 cpm, 16-h exposure), the NotI insert fragment of a quail
steonectin cDNA clone (7.1 3 107 cpm, 1-h exposure), the EcoRI insert
ragment of a quail VCB2 cDNA clone (4.6 3 107 cpm, 20-h exposure),
nd the EcoRI insert fragment of a quail WS5 cDNA clone (6.3 3 107
pm, 36-h exposure). The EcoRI insert fragment of a quail GAPDH
DNA clone (5.3 3 107 cpm, 5-h exposure) and the NotI–BamHI insert
ragment of a chicken ribosomal protein S17 cDNA clone (4.9 3 107
pm, 4-day exposure) were used as controls. The sizes of the viral RNA
nd of the mRNAs are: MC29, 5.7 kb; v-myc specified by pUHD10–
myc, 1.9 kb; c-myc, 2.3 kb; CSRP2, 0.9 kb; CO6, 1.0 kb; nov, 2.2 kb;
ro-a2(I) collagen, 5.5 kb; osteonectin, 2.2/1.8 kb; VCB2, 2.0 kb; WS5, 2.8
b; GAPDH, 1.4 kb; and S17, 0.6 kb.
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201CONDITIONAL CELL TRANSFORMATION BY v-myc986) and in rat fibroblasts transformed by ras or jun
ncogenes (Mettouchi et al., 1994). The quail osteonectin
ene isolated here displays 97% identity at the deduced
mino acid sequence level with the chicken homolog
Bassuk et al., 1993), and the two mRNA species of 1.8
nd 2.2 kb, respectively, are apparently generated by
ifferential polyadenylation (unpublished data).
VCB2 and WS5 are novel quail gene isolates whose
ifferential expression is specifically linked to v-myc-
nduced cell transformation rather than to cell transfor-
ation in general. While expression of VCB2 is specifi-
ally suppressed, transcription of WS5 is specifically
ctivated both in the nonconditionally transformed cell
ine Q8 and in the Q/tM8 cell line in the absence of
oxycycline, in comparison to the mRNA levels of these
wo genes in normal QEFs or in the reverted Q/tM8 cells
n the presence of doxycycline (Fig. 7). The suppression
f VCB2 and the activation of WS5 were not observed in
ibroblasts transformed by the src or jun oncogenes or in
hemically transformed quail fibroblasts (not shown).
artial nucleotide sequence analysis of VCB2 cDNA
lones revealed significant sequence similarity to a
DNA clone (GenBank accession no. U92535) encoding
he bovine homolog of NAP-22, a 22-kDa calmodulin-
inding neuronal acidic protein first isolated from rat
rain (Maekawa et al., 1993). Nucleotide sequence anal-
sis of incomplete WS5 cDNA clones corresponding to
he 39 third of the 2.8-kb WS5 mRNA (Fig. 7) revealed 63%
equence identity of the predicted protein product with
hicken MMP115, a 115-kDa melanosomal matrix protein
Mochii et al., 1991).
Control hybridizations with GAPDH and ribosomal S17
robes revealed that expression of both housekeeping
enes was reduced in Q/tM8 cells reverted by the addi-
ion of doxycycline. This lower expression level observed
n independent experiments using RNAs from reverted
ells of all five Q/tM clones is possibly due to a reduced
etabolic activity in these very slowly growing cells after
eversion from the transformed state (cf. Fig. 5).
DISCUSSION
The recent development of tetracycline-controlled
ransactivation systems for inducible gene expression
as greatly facilitated the temporal and quantitative con-
rol of exogenous genes in animal cells and allowed new
pproaches toward the elucidation of the downstream
ffects on cell physiology exerted by controlled changes
n gene expression patterns (Shockett and Schatz, 1996).
hese systems are based on two principal components:
ranscriptional transactivators that interact specifically
ith cis-acting prokaryotic control elements placed up-
tream of the eukaryotic gene of interest, and antibiotics
hat modulate the binding of the transactivators to such
lements at low, nontoxic concentrations. Compared
ith earlier approaches, the main advantages of the hetracycline-controlled systems are the absence of non-
pecific pleiotropic effects of the drugs used to control
he expression system; the tightness of transcriptional
ontrol allowing virtual on/off regulation of genes; and
he preservation of the authentic gene product, with no
eed for structural changes, like fusion with heterolo-
ous protein domains. Such structural changes, like fu-
ion with a hormone receptor domain, may lead to func-
ional alterations of the original gene product (Mol et al.,
995), and proteolytic processing of chimeric constructs
ay release the protein of interest from hormonal control
nd cause leakiness of the system (Kruse et al., 1997).
The principal result of the current study is the estab-
ishment of long-term quail embryo fibroblast lines con-
itionally transformed by inducible v-myc alleles that are
ependent on transcriptional transactivators controlled
y doxycycline, a tetracycline derivative. Molecular anal-
ses of v-myc mRNA and protein expression in these
ells revealed that the control of gene expression by the
ddition or removal of doxycyline is rapid and, most
mportantly, completely tight. The cellular parameters of
ransformation, like morphological alterations, anchor-
ge-independent growth, and enhanced proliferation,
re all dependent on continuous v-myc expression and
re fully reversible after repression or reexpression, re-
pectively, of the inducible v-myc allele. Interestingly, the
orphological alterations typical for v-myc-transformed
r reverted cells, respectively, occur with a significant
elay after activation or repression of the v-myc onco-
ene at the transcriptional and, subsequently, the trans-
ational level. This is probably due to the fact that an
nknown number of molecular processes downstream of
he initiating activation or suppression events are nec-
ssary for establishing the pleiotropic alterations of cel-
ular morphology and growth properties, including
hanges in cytoskeletal structures and cell adhesions.
urthermore, differential intrinsic stability of intermediate
rotein effectors may contribute to the delay in cellular
esponse to oncogene suppression.
A surprising feature of the conditional cell transforma-
ion system established here is the nearly complete
ithdrawal of rapidly growing transformed cells from the
ell cycle after repression of the regulatable v-myc allele
nd subsequent morphological reversion, despite the
ontinued presence of serum growth factors. The obser-
ation of cell cycle exit after v-myc inactivation is in full
greement with previous reports on conditional cell
ransformation by a Myc-glucocorticoid receptor chimera
Tikhonenko et al., 1995) or on conditional immortaliza-
ion of adult rat neuronal progenitor cells by a tetracy-
line-controlled v-myc allele (Hoshimaru et al., 1996).
oth established lines and acutely transformed fibroblast
ultures containing the Myc receptor chimera were re-
orted to withdraw from cell cycle completely or to grow
uch more slowly and to much lower densities afterormone deprivation (Tikhonenko et al., 1995). Immortal-
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202 OBERST ET AL.zed rat neuronal progenitor cells were reported to stop
roliferating and to differentiate into neurons after v-myc
nactivation, and it was concluded that suppression of
he v-myc allele may be sufficient to make proliferating
ells exit from cell cycle and induce terminal differenti-
tion (Hoshimaru et al., 1996). Also, it was recently re-
orted that inactivation of a temperature-sensitive Src
rotein in v-src-transformed rat fibroblasts induced cell
ycle exit in the presence of serum growth factors (John-
on et al., 1998). It was argued that this may be due to a
rowth-inhibitory environment generated by a distur-
ance of cytoskeletal structures and cell adhesions in
he transformed cells that is compatible with cell growth
nly in the presence of the active oncogene protein
roduct and is restored to normal only with a significant
elay after inactivation of the Src protein. Similar distur-
ances in conditionally v-myc-transformed cells may
ause cell cycle exit and prevent complete reversion to
ormal growth properties after inactivation of the onco-
ene. In other important aspects, our results are clearly
t variance with the report on conditional avian fibroblast
ransformation employing the Myc-glucocorticoid recep-
or chimera (Tikhonenko et al., 1995). It was reported that
oth established lines and acutely transformed fibro-
lasts sustain the transformed morphology and the abil-
ty of anchorage-independent growth even after pro-
onged hormone deprivation, and it was proposed that
mmortalization, transformed morphology, and anchor-
ge-independent growth are independent of v-myc ex-
ression but due to secondary mutational events in
hese cells. In contrast, it is demonstrated here that the
aintenance of the transformed state, including all these
arameters of oncogenic cell transformation, is depen-
ent on continuous expression of the MC29 v-myc allele,
n agreement with previous genetic and biochemical
nalyses of wildtype and nonconditional mutant forms of
his oncogene (Bister and Jansen, 1986). Our results
oint out that inactivation of a conditional v-myc allele in
ully transformed quail fibroblasts induces a cellular
tate comparable to replicative senescence (Campisi,
996) rather than to partial transformation. Intriguingly,
eactivation of the oncogene in these cells allows full
estoration of the transformed phenotype, including all
ellular and molecular parameters tested (cf. Figs. 3–5),
ndicating that expression of v-myc is sufficient to induce
eentry of the cell cycle and full establishment of the
ransformed state. It will be interesting to determine
hether the mechanisms leading to cell cycle exit after
nactivation of the transforming oncogene in transformed
ells are related to the pathways leading to cell cycle
rrest and premature senescence in primary human or
odent cells by expression of oncogenic ras or raf alleles
Lin et al., 1998; Serrano et al., 1997; Zhu et al., 1998).
The identification of the downstream targets of onco-
enic transcription factors like Myc and the rigorous
roof that such direct or indirect target genes are nec- assary or even sufficient mediators of the biological
ffects of these proteins have proved difficult. Cell trans-
ormation by such proteins apparently involves changes
n the expression patterns of multiple genes and may
ven depend on multiple interactions in the transcription
actor network. Although several candidate myc target
enes have been identified (Grandori and Eisenman,
997), including presumed direct transcriptional targets
ike the ornithine decarboxylase gene (Bello-Fernandez
t al., 1993), the pyrimidine biosynthetic CAD enzyme
ene (Boyd et al., 1998; Miltenberger et al., 1995), the
dc25A phosphatase gene (Galaktionov et al., 1996), and
DEAD box RNA helicase gene (Grandori et al., 1996),
he mechanisms of their transcriptional control in vivo
nd their possible role in myc-induced oncogenesis have
ot yet been rigorously assessed. For several other can-
idate genes, including the a-prothymosin gene (Eilers
t al., 1991; Mol et al., 1995), the thrombospondin-1 gene
Tikhonenko et al., 1996), and the telomerase hEST2
ubunit gene (Wang et al., 1998), it is not yet clear
hether they are direct or indirect targets of myc func-
ion. It is also conceivable that only a small percentage of
elevant myc target genes have been identified so far
Grandori and Eisenman, 1997). For the isolation of myc
arget genes directly involved in myc-induced cell trans-
ormation, a tight conditional transformation system will
e very useful. The tightness of the doxycycline-
ontrolled v-myc expression system de-
cribed here (cf. Figs. 2 and 4) is corroborated by the
omplete and reversible suppression of known transfor-
ation-sensitive genes in the conditionally v-myc-trans-
ormed cells, including the CSRP2, CO6, nov, pro-a2(I)
ollagen, and osteonectin gene (cf. Fig. 7). Transcrip-
ional suppression of these genes was also observed in
ells transformed by oncogenic agents other than myc
Mettouchi et al., 1994; Oberst et al., 1997; Scholz et al.,
996; Weiskirchen and Bister, 1993; Young et al., 1986),
ndicating that these genes probably are not direct tran-
criptional targets of Myc but that their suppression is
enerally linked to the transformed state of cells. Strik-
ngly, the on/off regulation of all of these marker genes in
/tM8 cells by doxycycline is nearly indistinguishable
rom the expression pattern observed when normal and
onconditionally v-myc-transformed QEFs are compared
cf. Fig. 7).
The cDNA clones VCB2 and WS5 isolated by subtrac-
ive hybridization represent two novel genes whose re-
ression (VCB2) or activation (WS5), respectively, was
bserved only in v-myc-transformed fibroblasts. Again,
he tight and reversible regulation of these genes in the
onditional system is a true reflection of their expression
attern in normal versus nonconditionally v-myc-trans-
ormed QEFs (cf. Fig. 7). Based on cDNA sequence
omology, the VCB2 protein product may represent the
uail homolog or a close relative of NAP-22, a member of
family of calmodulin-binding proteins including growth-
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203CONDITIONAL CELL TRANSFORMATION BY v-mycssociated protein (GAP)-43/neuromodulin (Maekawa et
l., 1993). These proteins are expressed in neuronal
rowth cones and are substrates of protein kinase C
Maekawa et al., 1994). Recently, the dysregulation of the
AP-43/neuromodulin gene in chicken embryo fibro-
lasts transformed by the v-src, v-qin, or v-jun oncogene
as been reported (Goller et al., 1998). Possibly, pertur-
ations of protein kinase C or Ca21-mediated signal
ransduction pathways caused by deregulation of genes
ncoding calmodulin-binding proteins is implicated in
ell transformation. The predicted protein product of the
S5 gene displays significant sequence similarities to a
amily of melanosomal proteins, with the chicken 115-
Da melanosomal matrix protein revealing the highest
egree of sequence identity (Mochii et al., 1991). Intrigu-
ngly, the quail melanocyte-specific gene QNR-71, which
s a member of this gene family but distinct from WS5,
as recently shown to be activated in quail neuroretina
ells transformed by v-myc and to be a direct transcrip-
ional target of the Myc protein (Turque et al., 1996).
nother member of this gene family encoding the mela-
osomal membrane protein Pmel17/gp100 is overex-
ressed in human malignant melanoma at all stages of
umor progression (Sarantou et al., 1997; Wagner et al.,
997). Further analyses of gene structure and transcrip-
ional regulation will be necessary to decide whether
CB2 and WS5 are direct transcriptional targets of Myc.
he tightly regulatable conditional transformation system
escribed here allowing temporal and quantitative con-
rol of v-myc expression will be an essential tool to
lucidate the downstream effects in v-myc-induced fibro-
last transformation.
MATERIALS AND METHODS
lasmids and DNA cloning
The plasmids pUHD15–1neo, pUHD17–1neo, and
UHD10–3, which constitute the inducible expression
ystem, and the luciferase response plasmid pUHC13–3
ere kindly provided by H. Bujard (Center for Molecular
iology, Heidelberg, Germany) (Gossen et al., 1995; Gos-
en and Bujard, 1992; Resnitzky et al., 1994). pUHD15–
neo contains the tTA transactivator gene, and pUHD17–
neo contains the rtTA reverse transactivator gene under
he control of the human cytomegalovirus immediate-
arly gene 1 promoter/enhancer. Plasmid pUHD10–3
ontains seven repeats of the tet operator O2 of the
n10-specified tetracycline-resistance operon from
scherichia coli fused to a human cytomegalovirus min-
mal promoter upstream of a polycloning site and the
imian virus 40 polyadenylation signal. Plasmid
MC29-B contains a 2.92-kbp BamHI fragment of wild-
ype MC29 proviral DNA encompassing most of gag and
ll of v-myc (Bister et al., 1982, 1987; Lautenberger et al.,
981; Reddy et al., 1983). To generate pUHD10–3myc, the
366-bp EcoRV–SspI fragment of pMC29-B containing bhe v-myc segment that corresponds to the entire c-myc
oding region was cloned into pUHD10–3 that had been
ut with EcoRI and filled in using the Klenow enzyme to
reate blunt ends. The structure of the construct was
onfirmed by restriction enzyme analysis and nucleotide
equencing by the dideoxynucleotide chain termination
ethod (Sanger et al., 1977) using a T7 sequencing kit
Pharmacia Biotech). The v-myc allele in pUHD10–3myc
ncodes a 54-kDa protein (p54v-myc) that is synthesized
y utilization of the authentic c-myc-derived translational
tart and stop codons and encompasses the myc-
pecific carboxyl-terminal 416 amino acids of the Gag–
yc hybrid protein (p110gag–myc) specified by MC29 (Bis-
er et al., 1977; Bister and Jansen, 1986).
ell culture
Fertile Japanese quail (Coturnix japonica) eggs were
btained from Hagn Geflu¨gel (Andorf, Austria). Primary
EFs were prepared according to a published procedure
Vogt, 1969). The established QEF nonproducer line Q8,
ransformed by the v-myc oncogene of avian retrovirus
C29, has been described previously (Bister et al., 1977).
ells were cultured in growth medium (Bister et al., 1977)
ased on Ham’s F-10 nutrient mixture with glutamine
GIBCO BRL) supplemented with 0.295% (w/v) tryptose
hosphate broth (DIFCO), 5% (v/v) newborn calf serum
GIBCO BRL), 2% (v/v) heat-inactivated chicken serum
GIBCO BRL), 1% (v/v) of a 1003 antibiotic–antimycotic
ixture (GIBCO BRL), 2.5% (v/v) of a 7.5% (w/v) sodium
icarbonate solution (GIBCO BRL), and 0.5% (v/v) dimeth-
lsulfoxide (Fluka). Cell cultures were maintained at
7°C in an atmosphere containing 5% carbon dioxide.
ells were trypsinized every 3–6 days and seeded at a
ensity of 2.5 3 106 cells/100-mm dish. At 1 day before
NA and protein extraction or before starting soft agar
olony assays, media were renewed. Cell numbers were
etermined by counting trypsinized cells in a Coulter
ounter. A stock solution (1 mg/ml) of the tetracycline-
erivative doxycycline (Sigma) in water was sterilized by
iltration and stored at 220°C. Doxycycline was added to
he culture medium at a final concentration of 1 mg/ml.
fter 2 days of incubation, the doxycycline concentration
as reduced to 50 ng/ml for cells containing the tTA-
ependent v-myc allele.
Soft agar colony assays were carried out according to
ublished procedures (Bister et al., 1977). Briefly,
rypsinized cells were adjusted to 106 cells/ml in TS
uffer (150 mM sodium chloride, 25 mM Tris–HCl pH 7.4,
mM potassium chloride, and 5 mM glucose) supple-
ented with 10% (v/v) newborn calf serum. Aliquots con-
aining 1 3 104, 2 3 104, or 2.5 3 105 cells were mixed
ith 2 ml of prewarmed (45°C) soft agar [Ham’s F-10
utrient mixture with glutamine supplemented with 0.36%
w/v) bactoagar (Difco), 0.295% (w/v) tryptose phosphate
roth, 10% (v/v) newborn calf serum, 4.6% (v/v) heat-
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204 OBERST ET AL.nactivated chicken serum, 1% (v/v) of a 1003 antibiotic–
ntimycotic mixture, 1.6% (v/v) of a 1003 vitamin solution
GIBCO BRL), 1.6% (v/v) of a 0.08% (w/v) solution of folic
cid (GIBCO BRL) in 8.4% (w/v) sodium bicarbonate, 1%
v/v) of a 1003 glutamine solution (GIBCO BRL), and 0.2%
v/v) dimethylsulfoxide] and poured onto 1 ml of bottom
gar [Ham’s F-10 nutrient mixture with glutamine supple-
ented with 0.75% (w/v) bactoagar, 0.295% (w/v) tryptose
hosphate broth, 3.5% (v/v) newborn calf serum, 1.25%
v/v) heat-inactivated chicken serum, 1% (v/v) of a 1003
ntibiotic–antimycotic mixture, 2.5% (v/v) of a 7.5% (w/v)
odium bicarbonate solution, 1% (v/v) of a 1003 glu-
amine solution (GIBCO BRL), and 1.25% (v/v) dimethyl-
ulfoxide] in 35-mm dishes. Where indicated, doxycy-
line was added to the soft agar at 1 mg/ml for QEF, Q8,
nd cells containing the rtTA-dependent v-myc allele and
t 50 ng/ml for cells containing the tTA-dependent v-myc
llele. Then, 1 ml of soft agar, with or without doxycy-
line, was overlaid every 2 days. Colonies were counted
fter 2 weeks.
For growth rate analysis, cells were seeded onto
5-mm dishes at a density of 2.5 3 105 cells/dish in
edium lacking doxycycline for cells expressing tTA or
t a density of 4.0 3 105 cells/dish in medium containing
oxycycline for cells expressing rtTA. The next day, me-
ium was changed, and one half of the dishes was
ncubated in the absence of doxycycline and one half
as incubated in the presence of doxycycline. Every 2
ays, the medium was renewed. All cell numbers were
etermined using cells from three parallel dishes.
NA transfection and generation of conditionally
ransformed cell lines
Secondary QEF were seeded in HBGM [Ham’s F-10
utrient mixture with glutamine supplemented with
0% (v/v) newborn calf serum, 25 mM HEPES, pH 7.3,
.4% (v/v) of a 7.5% (w/v) sodium bicarbonate solution,
nd 1% (v/v) of a 1003 antibiotic-antimycotic mixture]
t 4 3 106 cells/100-mm dish 24 h before transfection.
otransfection of 5 mg pUHD15–1neo and 5 mg
UHD10–3myc, or 5 mg pUHD17–1neo and 5 mg
UHD10–3myc, followed the calcium phosphate tech-
ique (Hartl and Bister, 1995; Hartl and Vogt, 1992). At
4 h after transfection, cells were split at a 1:4 ratio
nd plated in growth medium. G418 (75% biological
ctivity; Calbiochem) was applied at 400 mg/ml 48 h
fter transfection. Doxycycline at 1 mg/ml was in-
luded when cells were transfected with pUHD17–
neo encoding the rtTA transactivator. Two weeks af-
er transfection, independent clones of morphologi-
ally transformed cells were isolated using cloning
ylinders and propagated in growth medium without
418. For cells transfected with pUHD17–1neo, doxy-ycline was added to the medium. mmmunoblotting
Cells were trypsinized, counted, pelleted for 2 min at
3,000 rpm, and lysed at 1.25 3 104 cells/ml in protein
ample buffer (Kerkhoff and Bister, 1991) containing 60
M Tris–HCl (pH 6.8), 10% (v/v) glycerol, 5% (v/v) b-mer-
aptoethanol, 3% (w/v) SDS, and 0.005% (w/v) bromphe-
al blue. Protein samples derived from 1.25 3 105 cells
ach were separated by SDS–PAGE and blotted onto 0.2
m nitrocellulose membranes (Schleicher & Schuell).
locking of the membranes and incubation with antibod-
es were as described previously (Kerkhoff and Bister,
991) except that preblocking was for 3 h at room tem-
erature and incubation with the antiserum was carried
ut overnight at 4°C. Proteins were visualized using
CIP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitro
lue tetrazolium). The Myc-specific antiserum (used at a
ilution of 1:1400) was directed against recombinant
-Myc protein p14 containing the 103 carboxyl-terminal
mino acids of v-Myc encoded by a derivative of expres-
ion plasmid pEwtAB (Kerkhoff and Bister, 1991). The
RP2-specific antiserum (used at a dilution of 1:600) was
enerated by a method described previously (Hartl and
ister, 1998) using purified recombinant CRP2 protein
Konrat et al., 1998). A solution of 150 mg CRP2 in 0.5 ml
f water was mixed with 0.5 ml of complete Freund’s
djuvant and injected intradermally into an 8-week old
emale rabbit. Booster injections of 150 mg CRP2 each
sing incomplete Freund’s adjuvant were carried out
fter 30 and 56 days, and blood was collected 22 days
fter the last injection. Serum was obtained after over-
ight storage at 4°C and subsequent centrifugation at
200 g for 10 min.
NA isolation and Northern analysis
Cells grown to 80% confluency were rinsed at room
emperature with TS buffer and then lysed with 1 ml/107
ells of a buffer containing 25 mM sodium acetate, pH
.0, 4 M guanidine thiocyanate, and 0.835% (v/v) b-mer-
aptoethanol (Oberst et al., 1997; Weiskirchen and Bister,
993). The lysate was adjusted to 8 ml with lysis buffer;
ressed repeatedly through a 20-g needle; layered onto
4-ml cushion of a solution containing 25 mM sodium
cetate, pH 6.0, and 5.7 M cesium chloride; and then
entrifuged for 20 h at 21°C and 25,000 rpm in a Beck-
an SW41 rotor. The RNA pellet was resuspended in
ater; precipitated with ethanol in the presence of 300
M sodium acetate, pH 6.0; resuspended in water at
–10 mg/ml; and stored at 280°C.
For Northern analysis (Hartl et al., 1995; Oberst et al.,
997; Weiskirchen and Bister, 1993), 20 or 30 mg of total
ellular RNAs was separated by electrophoresis in 1%
w/v) agarose/2.2 M formaldehyde gels in a buffer con-
aining 20 mM MOPS, pH 7.0, 5 mM sodium acetate, and
mM EDTA. RNAs were transferred to Hybond-N nylon
embranes (Amersham) in 103 or 203 SSC (13 SSC 5
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205CONDITIONAL CELL TRANSFORMATION BY v-myc50 mM sodium chloride, 15 mM sodium citrate) and
mmobilized by heating for 2 h at 80°C. Blots were pre-
ybridized for 3–16 h and then hybridized for 12–16 h at
7°C to [a-32P]dCTP-labeled probes (Multiprime DNA
abeling system; Amersham) in a buffer containing 50%
v/v) formamide, 63 SSC, 53 Denhardt’s solution [0.1%
w/v) Ficoll 400, 0.1% (w/v) bovine serum albumin, 0.1%
olyvinylpyrrolidone], 5 mM EDTA, 0.5% (w/v) SDS, and
00 mg/ml sheared denatured herring sperm DNA. Filters
ere washed once at 55°C for 20 min in a solution
ontaining 23 SSC, 1 mM EDTA, and 0.1% (w/v) SDS and
hen twice at 50°C for 20 min in a solution containing
.43 SSC, 1 mM EDTA, and 0.1% (w/v) SDS. Autoradio-
raphs were exposed to Kodak X-OMAT AR film at
80°C using an intensifying screen. Before rehybridiza-
ion with a different probe, filters were incubated for 1 h
ach at 65°C and 70°C in a buffer containing 5 mM
ris–HCl, pH 8.0, 0.13 Denhardt’s solution, and 2 mM
DTA.
The following hybridization probes were used
where applicable, sizes of cDNA insert fragments
nclude 22 bp of EcoRI–NotI adaptor sequences): the
175-bp PstI–SspI myc-specific subfragment of
MC29-B (cf. Fig. 1), the 1040-bp SalI–BamHI myc-
pecific subfragment of pMC29-B (Bister et al., 1982,
987), the 793-bp EcoRI insert fragment of a quail
SRP2 cDNA clone (Weiskirchen and Bister, 1993), the
41-bp EcoRI insert fragment of a quail CO6 cDNA
lone (Oberst et al., 1997), the 1940-bp NotI insert
ragment of a quail nov cDNA clone (R. Weiskirchen
nd K. Bister, unpublished data; GenBank accession
o. U13063), the 1653-bp NotI insert fragment of a
uail pro-a2(I) collagen cDNA clone (R. Weiskirchen
nd K. Bister, unpublished data; GenBank accession
o. AF077329), the 2131-bp NotI insert fragment of a
uail osteonectin cDNA clone (R. Weiskirchen and K.
ister, unpublished data; GenBank accession no.
F077327), the ;0.66-kbp EcoRI insert fragment of a
uail VCB2 cDNA clone (M. Hartl and K. Bister, unpub-
ished data; GenBank accession no. AF077305), the
41-bp EcoRI insert fragment of a quail WS5 cDNA
lone (R. Weiskirchen and K. Bister, unpublished data;
enBank accession no. AF077328); the 1235-bp EcoRI
nsert fragment of a quail GAPDH cDNA clone
Weiskirchen et al., 1993), and the 380-bp NotI–BamHI
nsert fragment of a plasmid clone (kindly provided by
.-H. Klempnauer, University of Mu¨nster, Germany)
epresenting chicken ribosomal S17 cDNA (Trueb et
l., 1988).
cDNA library construction, subtracted probe prepara-
ion, DNA labeling, plaque hybridization, autoradiogra-
hy, subcloning of phage DNA, nucleotide sequencing of
NA insert fragments, and sequence interpretation were
erformed as described previously (Hartl and Bister,
995; Oberst et al., 1997; Weiskirchen and Bister, 1993). GACKNOWLEDGMENTS
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